focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,116.00
Bid: 12,114.00
Ask: 12,118.00
Change: -56.00 (-0.46%)
Spread: 4.00 (0.033%)
Open: 12,180.00
High: 12,198.00
Low: 12,076.00
Prev. Close: 12,172.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: UBS Upgrades AstraZeneca To Neutral

Mon, 30th Nov 2020 09:49

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

----------

FTSE 100

----------

UBS RAISES ASTRAZENECA TO 'NEUTRAL' (SELL) - PRICE TARGET 7,500 (7,300) PENCE

----------

BARCLAYS RAISES UNILEVER PRICE TARGET TO 5,500 (5,420) PENCE - 'OVERWEIGHT'

----------

UBS RAISES MELROSE INDUSTRIES PRICE TARGET TO 185 (134) PENCE - 'BUY'

----------

MORGAN STANLEY RAISES WHITBREAD TARGET TO 3,000 (2,700) PENCE - 'EQUAL-WEIGHT'

----------

BARCLAYS RAISES SPIRAX-SARCO PRICE TARGET TO 9,925 (9,380) PENCE - 'EQUAL WEIGHT'

----------

RBC RAISES NEXT PRICE TARGET TO 7,000 (6,500) PENCE - 'SECTOR PERFORM'

----------

RBC RAISES ASSOCIATED BRITISH FOODS PRICE TARGET TO 2,300 (2,100) PENCE - 'OUTPERFORM'

----------

RBC RAISES ANTOFAGASTA PRICE TARGET TO 1,080 (780) PENCE - 'UNDERPERFORM'

----------

RBC RAISES RIO TINTO PRICE TARGET TO 5,900 (5,000) PENCE - 'SECTOR PERFORM'

----------

RBC RAISES BHP GROUP PRICE TARGET TO 2,400 (2,000) PENCE - 'OUTPERFORM'

----------

RBC RAISES GLENCORE PRICE TARGET TO 280 (240) PENCE - 'OUTPERFORM'

----------

RBC RAISES ANGLO AMERICAN PRICE TARGET TO 3,400 (2,400) PENCE - 'OUTPERFORM'

----------

GOLDMAN SACHS CUTS AVEVA GROUP PRICE TARGET TO 3,600 (4,011) PENCE - 'NEUTRAL'

----------

GOLDMAN SACHS RAISES STANDARD LIFE ABERDEEN PRICE TARGET TO 298 (260) PENCE - 'BUY'

----------

GOLDMAN SACHS RAISES SCHRODERS PRICE TARGET TO 2,465 (2,195) PENCE - 'SELL'

----------

JEFFERIES RAISES AVIVA PRICE TARGET TO 400 (350) PENCE - 'BUY'

----------

BANK OF AMERICA RAISES AVIVA PRICE TARGET TO 375 (360) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES OCADO PRICE TARGET TO 2,000 (1,800) PENCE - 'NEUTRAL'

----------

FTSE 250

----------

RBC RAISES DUNELM GROUP TO 'OUTPERFORM' ('SECTOR PERFORM') - TARGET 1,450 PENCE

----------

RBC RAISES MARKS & SPENCER PRICE TARGET TO 145 (120) PENCE - 'OUTPERFORM'

----------

MORGAN STANLEY RAISES BEAZLEY PRICE TARGET TO 390 (350) PENCE - 'EQUAL-WEIGHT'

----------

MORGAN STANLEY RAISES LANCASHIRE PRICE TARGET TO 1,065 (1,045) P - 'OVERWEIGHT'

----------

MORGAN STANLEY RAISES HISCOX PRICE TARGET TO 1450 (990) PENCE - 'OVERWEIGHT'

----------

BARCLAYS RAISES VESUVIUS PRICE TARGET TO 500 (400) PENCE - 'EQUAL WEIGHT'

----------

BARCLAYS CUTS CARNIVAL PRICE TARGET TO 1,725 (2,250) PENCE - 'OVERWEIGHT'

----------

GOLDMAN SACHS RAISES MAN GROUP PRICE TARGET TO 140 (135) PENCE - 'NEUTRAL'

----------

GOLDMAN SACHS RAISES ASHMORE GROUP PRICE TARGET TO 435 (420) PENCE - 'BUY'

----------

JPMORGAN CUTS BODYCOTE TO 'UNDERWEIGHT' ('NEUTRAL') - TARGET 635 (670) PENCE

----------

BARCLAYS RAISES BODYCOTE PRICE TARGET TO 715 (620) PENCE - 'EQUAL WEIGHT'

----------

JPMORGAN RAISES MITCHELLS & BUTLERS TARGET TO 360 (340) PENCE - 'OVERWEIGHT'

----------

BANK OF AMERICA RAISES BALFOUR BEATTY PRICE TARGET TO 350 (345) PENCE - 'BUY'

----------

OTHER MAIN MARKET AND AIM

----------

UBS RAISES KINGSPAN GROUP PRICE TARGET TO 60 (55) EUR - 'SELL'

----------

BERENBERG RAISES VICTORIA PRICE TARGET TO 770 (330) PENCE - 'BUY'

----------

BARCLAYS CUTS NEWRIVER REIT PRICE TARGET TO 72 (76) PENCE - 'EQUAL WEIGHT'

----------

RBC RAISES CENTRAL ASIA METALS TO 'OUTPERFORM' ('SECTOR PERFORM') - TARGET 270 (170) PENCE

----------

RBC RAISES ANGLO PACIFIC GROUP PRICE TARGET TO 205 (195) PENCE - 'OUTPERFORM'

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.